Harvard Bioscience Balance Sheet
Harvard Bioscience's total assets for Q4 2025 were $80.07M, an increase of 2.67% from the previous quarter. HBIO total liabilities were $66.34M for the fiscal quarter, a 3.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.